Caribou Biosciences (CRBU) Other Non-Current Assets (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Other Non-Current Assets data on file, last reported at $2.1 million in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $2.1 million, down 57.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 million (down 57.62% YoY), and the FY2025 annual result was $2.2 million, down 60.15% from the prior year.
• Other Non-Current Assets eased to $2.1 million in Q1 2026 per CRBU's latest filing, from $2.2 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $5.5 million in Q4 2024 and troughed at $1.3 million in Q2 2022.
• A 5-year average of $2.5 million and a median of $1.6 million in 2024 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets tumbled 61.63% in 2022, then jumped 248.11% in 2024.
• A 5-year view of Other Non-Current Assets shows it stood at $1.5 million in 2022, then gained by 3.12% to $1.6 million in 2023, then jumped by 248.11% to $5.5 million in 2024, then slumped by 60.15% to $2.2 million in 2025, then declined by 2.86% to $2.1 million in 2026.
• Business Quant data shows CRBU's Other Non-Current Assets at $2.1 million in Q1 2026, $2.2 million in Q4 2025, and $3.8 million in Q3 2025.